https://www.benzinga.com/markets/cannabis/21/12/24741874/organigram-invests-additional-2-5m-in-cbd-biotech-co-hyasynth-wraps-up-10m-debenture-purchase-de
Organigram Invests Additional $2.5M In CBD Biotech Co Hyasynth, Wraps Up $10M Debenture Purchase...
Dec 22, 2021 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has acquired an additional $2.5 million of secured convertible debentures in Hyasynth Biologicals Inc.